Home / Tag Archives: Siliq

News: Siliq


Siliq (brodalumab) FDA Approval

Siliq

Company: Valeant Pharmaceuticals Approval Status: Approved February 2017 Specific Treatments: plaque psoriasis Therapeutic Areas Dermatology General Information Siliq (brodalumab) is a human interleukin-17 receptor A (IL-17RA) antagonist. Siliq is specifically indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to …

Read More »